The global catheter introducer sheaths market accounted for USD 1.18 billion in 2023 and is expected to reach at USD 2.59 billion by 2034 with a CAGR of 7.42% during the forecast period 2024-2034. Rising prevalence of cardiovascular disease, growing preference for minimally invasive procedures, increasing investment by both private & public sectors in healthcare, surge in technological advancements, and growing introduction of innovative catheter introducer sheaths are some of the key factors boosting the market growth.
Growing introduction of innovative catheter introducer sheaths is predicted to boost the market growth during the forecast period. As cardiovascular diseases become more prevalent, there is a growing need for advanced devices such as catheter introducer sheaths, which facilitate the introduction of interventional tools into the patient's vascular system. For instance, in April 2022, Inari Medical introduced the Intri24 introducer sheath, designed for use alongside the Triever20 and Triever24 catheters to facilitate large-bore venous access.
By product, integrated introducer sheaths was the highest revenue-grossing segment in the global catheter introducer sheaths market in 2023 owing to the smooth design of these sheaths aims to simplify procedures, improve workflow efficiency, & reduce the risk of air embolism during catheter insertion, growing demand for minimally invasive procedures, ongoing advancements in interventional techniques, and increased acquisitions among market players. For instance, In April of 2022, Medtronic acquired Acutus Medical's left heart access product line for $50 million. Among the items in this assortment are the AcQGuide FLEX maneuverable introducer, the AcQGuide VUE flexible sheath, and the AcQGuide MINI combined crossing sheath and device. Additionally, separable introducer sheaths is predicted to grow at the fastest CAGR during the forecast period owing to the increasing technological advancements aim to enhance the overall patient experience and rise in research & development investment aimed at introducing innovative introducer sheaths.
By application, cardiology was the highest revenue-grossing segment in the global catheter introducer sheaths market in 2023 owing to the increasing prevalence of obesity & hypertension, along with other risk factors for cardiovascular diseases, growing demand for advanced & efficient treatment options. Additionally, vascular is predicted to grow at the fastest CAGR during the forecast period owing to the rise in vascular diseases such as atherosclerosis, deep vein thrombosis, pulmonary embolism, & various cardiac disorders, increased demand for the diagnosis & treatment of these conditions among hospitals & surgery centers, and growing number of approvals by regulatory bodies. For instance, in November 2023, The Giranel Guiding Sheath, developed by Kossel Medtech, has obtained approval from the Jiangsu Medical Products Administration for its release in the market. This sheath is specifically designed for percutaneous puncture and insertion into the vascular system, aiding in the introduction of catheters, balloon catheters, or stents for interventional diagnostic or therapeutic purposes.
By end-user, hospitals was the highest revenue-grossing segment in the global catheter introducer sheaths market in 2023 owing to the increasing demand for ongoing supervision and upsurge in government investment in healthcare sector research & development. For instance, in October 2022, Cordis, a global frontrunner in the creation and production of interventional cardiovascular and endovascular technologies, revealed its acquisition of MedAlliance, a Switzerland-based company renowned for pioneering drug-eluting balloons. This acquisition is contingent upon standard closing conditions, including regulatory approvals. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to the increasing occurrence of cardiovascular ailments and rising uptake of advanced technologies within these facilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing understanding of the advantages linked with employing catheter introducer sheaths, heightened government involvement in advancing the healthcare sector, rise in the occurrence of various heart conditions such as coronary artery disease, cardiovascular disease, stroke, congestive heart failure, & arrhythmia, and increase in regulatory approvals. For instance, in February 2023, Biotronik has declared that its multifunctional peripheral catheter, named Oscar (One Solution: Cross. Adjust. Restore), has received clearance from the Food and Drug Administration (FDA) through the 510(k) process and has obtained the CE mark. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for minimally invasive procedures, increasing elderly population, growing investment by key players in research & development, and surge in approvals from regulatory bodies. For instance, in June 2022, Peijia Medical Ltd. has been granted two marketing approvals by the National Medical Products Administration (NMPA) of China for its catheters designed for use in neurointerventional surgery. These approvals pertain to Peijia's catheter offerings, specifically the balloon guide catheter (BGC) Fluxcap and the delivery balloon dilation catheter Fastunnel, both developed by their wholly owned subsidiary, Achieva Medical Ltd.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Growing introduction of innovative catheter introducer sheaths is predicted to boost the market growth during the forecast period. As cardiovascular diseases become more prevalent, there is a growing need for advanced devices such as catheter introducer sheaths, which facilitate the introduction of interventional tools into the patient's vascular system. For instance, in April 2022, Inari Medical introduced the Intri24 introducer sheath, designed for use alongside the Triever20 and Triever24 catheters to facilitate large-bore venous access.
By product, integrated introducer sheaths was the highest revenue-grossing segment in the global catheter introducer sheaths market in 2023 owing to the smooth design of these sheaths aims to simplify procedures, improve workflow efficiency, & reduce the risk of air embolism during catheter insertion, growing demand for minimally invasive procedures, ongoing advancements in interventional techniques, and increased acquisitions among market players. For instance, In April of 2022, Medtronic acquired Acutus Medical's left heart access product line for $50 million. Among the items in this assortment are the AcQGuide FLEX maneuverable introducer, the AcQGuide VUE flexible sheath, and the AcQGuide MINI combined crossing sheath and device. Additionally, separable introducer sheaths is predicted to grow at the fastest CAGR during the forecast period owing to the increasing technological advancements aim to enhance the overall patient experience and rise in research & development investment aimed at introducing innovative introducer sheaths.
By application, cardiology was the highest revenue-grossing segment in the global catheter introducer sheaths market in 2023 owing to the increasing prevalence of obesity & hypertension, along with other risk factors for cardiovascular diseases, growing demand for advanced & efficient treatment options. Additionally, vascular is predicted to grow at the fastest CAGR during the forecast period owing to the rise in vascular diseases such as atherosclerosis, deep vein thrombosis, pulmonary embolism, & various cardiac disorders, increased demand for the diagnosis & treatment of these conditions among hospitals & surgery centers, and growing number of approvals by regulatory bodies. For instance, in November 2023, The Giranel Guiding Sheath, developed by Kossel Medtech, has obtained approval from the Jiangsu Medical Products Administration for its release in the market. This sheath is specifically designed for percutaneous puncture and insertion into the vascular system, aiding in the introduction of catheters, balloon catheters, or stents for interventional diagnostic or therapeutic purposes.
By end-user, hospitals was the highest revenue-grossing segment in the global catheter introducer sheaths market in 2023 owing to the increasing demand for ongoing supervision and upsurge in government investment in healthcare sector research & development. For instance, in October 2022, Cordis, a global frontrunner in the creation and production of interventional cardiovascular and endovascular technologies, revealed its acquisition of MedAlliance, a Switzerland-based company renowned for pioneering drug-eluting balloons. This acquisition is contingent upon standard closing conditions, including regulatory approvals. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to the increasing occurrence of cardiovascular ailments and rising uptake of advanced technologies within these facilities.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing understanding of the advantages linked with employing catheter introducer sheaths, heightened government involvement in advancing the healthcare sector, rise in the occurrence of various heart conditions such as coronary artery disease, cardiovascular disease, stroke, congestive heart failure, & arrhythmia, and increase in regulatory approvals. For instance, in February 2023, Biotronik has declared that its multifunctional peripheral catheter, named Oscar (One Solution: Cross. Adjust. Restore), has received clearance from the Food and Drug Administration (FDA) through the 510(k) process and has obtained the CE mark. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for minimally invasive procedures, increasing elderly population, growing investment by key players in research & development, and surge in approvals from regulatory bodies. For instance, in June 2022, Peijia Medical Ltd. has been granted two marketing approvals by the National Medical Products Administration (NMPA) of China for its catheters designed for use in neurointerventional surgery. These approvals pertain to Peijia's catheter offerings, specifically the balloon guide catheter (BGC) Fluxcap and the delivery balloon dilation catheter Fastunnel, both developed by their wholly owned subsidiary, Achieva Medical Ltd.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Application, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Catheter Introducer Sheaths Market Report 2023 - 2034
Catheter Introducer Sheaths Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Separable Introducer Sheaths
- Integrated Introducer Sheaths
Catheter Introducer Sheaths Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Vascular
- Neurology
- Cardiology
- Others
Catheter Introducer Sheaths Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgical Centers
- Others
Catheter Introducer Sheaths Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Catheter Introducer Sheaths Market: Product Estimates & Trend Analysis
8. Catheter Introducer Sheaths Market: Application Estimates & Trend Analysis
9. Catheter Introducer Sheaths Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Catheter Introducer Sheaths Market
12. Europe Global Catheter Introducer Sheaths Market
13. Asia Pacific Global Catheter Introducer Sheaths Market
14. Latin America Global Catheter Introducer Sheaths Market
15. MEA Global Catheter Introducer Sheaths Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Medtronic
- Stryker
- Oscor Inc
- Merit Medical
- BD
- Cordis Corporation
- Abbott
- Terumo Corporation
- Galt Medical Corporation
- B. Braun Interventional Systems Inc.
